📊

Exploring Epic Cosmos in Pediatric Research

Feb 18, 2025

Lecture Introduction: Dr. Lindsay Knaik

  • Role and Affiliation: Visiting from the University of Iowa
    • Professor of Metrics
    • Associate CMIO at Stead Family Children's Hospital
  • Background
    • Biomedical engineering and medical school in Iowa
    • Residency at Baylor in pediatrics
    • Fellowship in neonatology at Vanderbilt
    • Informatics background

Overview of Epic Cosmos

  • What is Cosmos?
    • Research-related sharing network with Epic
    • Contains de-identified clinical EHR data from Epic institutions
    • 203 million patients, billions of encounters
  • Benefits
    • Large database of clinical information
    • Fast query abilities, similar demographic spin to U.S. Census
    • Contains longitudinal patient charts and diverse datasets

Using Epic Cosmos

  • Access Requirements
    • Belong to Epic Institution
    • Epic classes needed for access
  • Data Available
    • Slicer dicer version: limited aggregate data
    • Data science side: line level detailed data

Example Study: Neonatal Hypertension

  • Research Setup
    • Started with slicer dicer for cohort creation
    • Validation using clinical knowledge
  • Findings
    • 1.7% diagnosis rate, consistent with literature
    • Medication patterns observed: ACE inhibitors, calcium channel blockers
    • Showed the power of Cosmos for large-scale analysis

Challenges and Feedback

  • Data Quality and Limitations
    • Examples of mapping issues in care everywhere
    • Importance of validating datasets
  • Sidekick Tool
    • Large language model in slicer dicer
    • Tested to improve query building
    • Needs clinical validation for accuracy

Cosmos Collaboration and Research

  • Collaborations
    • Early adopters provide feedback
    • Multidisciplinary teams for validated cohorts
  • Epic Research
    • Epic publishes findings to showcase Cosmos
    • Caution in definitions used by Epic teams

Case Study: Tiny Baby Program

  • Objective: Analyze outcomes for extremely preterm infants
  • Methodology
    • Comparison with historical data
    • Study of survival rates, medication use
  • Results
    • Survival improvement in 22-weekers
    • Validated use of Cosmos for neonatal health trends

Future Directions

  • Potential Improvements
    • Enhanced data quality dashboards
    • More structured note data
  • Access and Training
    • Legal and mapping issues
    • Training available online and virtually

Conclusion

  • Cosmos is a powerful, evolving tool
  • Important for large-scale and multi-center research
  • Continued feedback necessary to improve data quality and usability
  • Encouragement for institutions to join and contribute to Cosmos